Glass market studies

Global Glass Vial for Vaccine Market Research Report 2021

  

Summary

The global Glass Vial for Vaccine market was valued at US$ XX million in 2019 and is expected to reach US$ XX million by the end of 2026, growing at a CAGR of XX% during 2021-2026.
This report focuses on Glass Vial for Vaccine volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Glass Vial for Vaccine market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Glass Vial for Vaccine Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Molded Glass Vial
Tubular Glass Vial

Segment by Application
Preventive Vaccine
Therapeutic Vaccine

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Schott AG
DWK Life Sciences
Richland Glass
Nipro
Pacific Vial Manufacturing
Origin Ltd
Stevanato Group
SGD Pharma
Piramal Glass
Zheng Chuan
Shandong Pharmaceutical Glass
Zheng Li
Gerresheimer
Four Stars Glass
JOTOP Glass


Detailed TOC of Global Glass Vial for Vaccine Market Research Report 2021
1 Glass Vial for Vaccine Market Overview
1.1 Product Overview and Scope of Glass Vial for Vaccine
1.2 Glass Vial for Vaccine Segment by Type
1.2.1 Global Glass Vial for Vaccine Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Molded Glass Vial
1.2.3 Tubular Glass Vial
1.3 Glass Vial for Vaccine Segment by Application
1.3.1 Glass Vial for Vaccine Sales Comparison by Application: (2021-2027)
1.3.2 Preventive Vaccine
1.3.3 Therapeutic Vaccine
1.4 Global Glass Vial for Vaccine Market Size Estimates and Forecasts
1.4.1 Global Glass Vial for Vaccine Revenue 2016-2027
1.4.2 Global Glass Vial for Vaccine Sales 2016-2027
1.4.3 Glass Vial for Vaccine Market Size by Region: 2016 Versus 2021 Versus 2027

2 Glass Vial for Vaccine Market Competition by Manufacturers
2.1 Global Glass Vial for Vaccine Sales Market Share by Manufacturers (2016-2021)
2.2 Global Glass Vial for Vaccine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Glass Vial for Vaccine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Glass Vial for Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Glass Vial for Vaccine Market Competitive Situation and Trends
2.5.1 Glass Vial for Vaccine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Glass Vial for Vaccine Players Market Share by Revenue
2.5.3 Global Glass Vial for Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Glass Vial for Vaccine Retrospective Market Scenario by Region
3.1 Global Glass Vial for Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Glass Vial for Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Glass Vial for Vaccine Market Facts & Figures by Country
3.3.1 North America Glass Vial for Vaccine Sales by Country
3.3.2 North America Glass Vial for Vaccine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Glass Vial for Vaccine Market Facts & Figures by Country
3.4.1 Europe Glass Vial for Vaccine Sales by Country
3.4.2 Europe Glass Vial for Vaccine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Glass Vial for Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Glass Vial for Vaccine Sales by Region
3.5.2 Asia Pacific Glass Vial for Vaccine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Glass Vial for Vaccine Market Facts & Figures by Country
3.6.1 Latin America Glass Vial for Vaccine Sales by Country
3.6.2 Latin America Glass Vial for Vaccine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Glass Vial for Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Glass Vial for Vaccine Sales by Country
3.7.2 Middle East and Africa Glass Vial for Vaccine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Glass Vial for Vaccine Historic Market Analysis by Type
4.1 Global Glass Vial for Vaccine Sales Market Share by Type (2016-2021)
4.2 Global Glass Vial for Vaccine Revenue Market Share by Type (2016-2021)
4.3 Global Glass Vial for Vaccine Price by Type (2016-2021)

5 Global Glass Vial for Vaccine Historic Market Analysis by Application
5.1 Global Glass Vial for Vaccine Sales Market Share by Application (2016-2021)
5.2 Global Glass Vial for Vaccine Revenue Market Share by Application (2016-2021)
5.3 Global Glass Vial for Vaccine Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Schott AG
6.1.1 Schott AG Corporation Information
6.1.2 Schott AG Description and Business Overview
6.1.3 Schott AG Glass Vial for Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Schott AG Product Portfolio
6.1.5 Schott AG Recent Developments/Updates
6.2 DWK Life Sciences
6.2.1 DWK Life Sciences Corporation Information
6.2.2 DWK Life Sciences Description and Business Overview
6.2.3 DWK Life Sciences Glass Vial for Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.2.4 DWK Life Sciences Product Portfolio
6.2.5 DWK Life Sciences Recent Developments/Updates
6.3 Richland Glass
6.3.1 Richland Glass Corporation Information
6.3.2 Richland Glass Description and Business Overview
6.3.3 Richland Glass Glass Vial for Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Richland Glass Product Portfolio
6.3.5 Richland Glass Recent Developments/Updates
6.4 Nipro
6.4.1 Nipro Corporation Information
6.4.2 Nipro Description and Business Overview
6.4.3 Nipro Glass Vial for Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Nipro Product Portfolio
6.4.5 Nipro Recent Developments/Updates
6.5 Pacific Vial Manufacturing
6.5.1 Pacific Vial Manufacturing Corporation Information
6.5.2 Pacific Vial Manufacturing Description and Business Overview
6.5.3 Pacific Vial Manufacturing Glass Vial for Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Pacific Vial Manufacturing Product Portfolio
6.5.5 Pacific Vial Manufacturing Recent Developments/Updates
6.6 Origin Ltd
6.6.1 Origin Ltd Corporation Information
6.6.2 Origin Ltd Description and Business Overview
6.6.3 Origin Ltd Glass Vial for Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Origin Ltd Product Portfolio
6.6.5 Origin Ltd Recent Developments/Updates
6.7 Stevanato Group
6.6.1 Stevanato Group Corporation Information
6.6.2 Stevanato Group Description and Business Overview
6.6.3 Stevanato Group Glass Vial for Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Stevanato Group Product Portfolio
6.7.5 Stevanato Group Recent Developments/Updates
6.8 SGD Pharma
6.8.1 SGD Pharma Corporation Information
6.8.2 SGD Pharma Description and Business Overview
6.8.3 SGD Pharma Glass Vial for Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.8.4 SGD Pharma Product Portfolio
6.8.5 SGD Pharma Recent Developments/Updates
6.9 Piramal Glass
6.9.1 Piramal Glass Corporation Information
6.9.2 Piramal Glass Description and Business Overview
6.9.3 Piramal Glass Glass Vial for Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Piramal Glass Product Portfolio
6.9.5 Piramal Glass Recent Developments/Updates
6.10 Zheng Chuan
6.10.1 Zheng Chuan Corporation Information
6.10.2 Zheng Chuan Description and Business Overview
6.10.3 Zheng Chuan Glass Vial for Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Zheng Chuan Product Portfolio
6.10.5 Zheng Chuan Recent Developments/Updates
6.11 Shandong Pharmaceutical Glass
6.11.1 Shandong Pharmaceutical Glass Corporation Information
6.11.2 Shandong Pharmaceutical Glass Glass Vial for Vaccine Description and Business Overview
6.11.3 Shandong Pharmaceutical Glass Glass Vial for Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Shandong Pharmaceutical Glass Product Portfolio
6.11.5 Shandong Pharmaceutical Glass Recent Developments/Updates
6.12 Zheng Li
6.12.1 Zheng Li Corporation Information
6.12.2 Zheng Li Glass Vial for Vaccine Description and Business Overview
6.12.3 Zheng Li Glass Vial for Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Zheng Li Product Portfolio
6.12.5 Zheng Li Recent Developments/Updates
6.13 Gerresheimer
6.13.1 Gerresheimer Corporation Information
6.13.2 Gerresheimer Glass Vial for Vaccine Description and Business Overview
6.13.3 Gerresheimer Glass Vial for Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Gerresheimer Product Portfolio
6.13.5 Gerresheimer Recent Developments/Updates
6.14 Four Stars Glass
6.14.1 Four Stars Glass Corporation Information
6.14.2 Four Stars Glass Glass Vial for Vaccine Description and Business Overview
6.14.3 Four Stars Glass Glass Vial for Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Four Stars Glass Product Portfolio
6.14.5 Four Stars Glass Recent Developments/Updates
6.15 JOTOP Glass
6.15.1 JOTOP Glass Corporation Information
6.15.2 JOTOP Glass Glass Vial for Vaccine Description and Business Overview
6.15.3 JOTOP Glass Glass Vial for Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.15.4 JOTOP Glass Product Portfolio
6.15.5 JOTOP Glass Recent Developments/Updates

7 Glass Vial for Vaccine Manufacturing Cost Analysis
7.1 Glass Vial for Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Glass Vial for Vaccine
7.4 Glass Vial for Vaccine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Glass Vial for Vaccine Distributors List
8.3 Glass Vial for Vaccine Customers

9 Glass Vial for Vaccine Market Dynamics
9.1 Glass Vial for Vaccine Industry Trends
9.2 Glass Vial for Vaccine Growth Drivers
9.3 Glass Vial for Vaccine Market Challenges
9.4 Glass Vial for Vaccine Market Restraints

10 Global Market Forecast
10.1 Glass Vial for Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Glass Vial for Vaccine by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Glass Vial for Vaccine by Type (2022-2027)
10.2 Glass Vial for Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Glass Vial for Vaccine by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Glass Vial for Vaccine by Application (2022-2027)
10.3 Glass Vial for Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Glass Vial for Vaccine by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Glass Vial for Vaccine by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer


Info Grid

glassglobal Group / OGIS GmbH


Grafenberger-Allee 277-287
40237 Düsseldorf (Germany)
Phone +49 (0)211 - 280733-0
Fax +49 (0)211 - 280733-22
Email office at glassglobal dot com


Discounts when buying 2 or more


Buy 2 studies to get 15% discount.
Buy 3 or more studies to get 20% discount.

Note: Your inquiry is no binding purchase